Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
05/30/2003 | WO2002086068A3 Methods for producing recombinant coronavirus |
05/30/2003 | WO2002077029A3 Cd19-specific redirected immune cells |
05/30/2003 | WO2002076501A3 Blood cell production via activation of the hemoglobin scavenger receptor |
05/30/2003 | WO2002068632A3 Methods to identify mutant cells with altered sialic acid |
05/30/2003 | WO2002068594A3 Opiate receptors |
05/30/2003 | WO2002067856A3 Injection molding of living tissues |
05/30/2003 | WO2002067812A3 Tympanic membrane patch |
05/30/2003 | WO2002064790A3 Jfy1 protein induces rapid apoptosis |
05/30/2003 | WO2002064621A3 Histidine proline rich glycoprotein (hprg) as an anti-angiogenic and anti-tumor agent |
05/30/2003 | WO2002057314A3 Prevention and treatment of hcv infection employing antibodies directed against conformational epitopes |
05/30/2003 | WO2002053728A9 Gene disruption methodologies for drug target discovery |
05/30/2003 | WO2002051868A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
05/30/2003 | WO2002050309A3 A bardet-biedl susceptibility gene and uses thereof |
05/30/2003 | WO2002030443A3 Regulation of human skin healing |
05/30/2003 | WO2002006328A3 Type 2 dendritic cell precursor derived coding nucleic acids and related compositions and methods |
05/30/2003 | WO2002000692A9 Pd-l2 molecules: pd-1 ligands and uses therefor |
05/30/2003 | WO2001092542A3 Integrin-targeting vectors having enhanced transfection activity |
05/30/2003 | WO2001080760A8 Method for expansion of epithelial stem cells |
05/30/2003 | CA2468088A1 Novel peptides conferring environmental stress resistance and fusion proteins including said peptides |
05/30/2003 | CA2467930A1 Treatment of pml targeting jc virus agno |
05/30/2003 | CA2467927A1 Antimicrobial polypeptides from pseudoplectania nigrella |
05/30/2003 | CA2467819A1 Improvement of viability and function of pancreatic islets |
05/30/2003 | CA2467223A1 Method for extending the useful shelf-life of refrigerated red blood cells by nutrient supplementation |
05/30/2003 | CA2467206A1 Genes encoding g-protein coupled receptors and methods of use therefor |
05/30/2003 | CA2467195A1 Matrix for the production of tissue engineered ligaments, tendons and other tissue |
05/30/2003 | CA2467181A1 Peptides promoting cell adherence, growth and secretion |
05/30/2003 | CA2466937A1 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen |
05/30/2003 | CA2466903A1 Ectocornea-like sheet and method of constructing the same |
05/30/2003 | CA2466578A1 Methods and devices for the integrated discovery of cell culture environments |
05/30/2003 | CA2464957A1 Polypeptides of moraxella (branhamella) catarrhalis |
05/30/2003 | CA2463790A1 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
05/30/2003 | CA2445078A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof |
05/30/2003 | CA2407302A1 Genes transfection into bony tissues |
05/29/2003 | US20030101489 DNA encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5A, transgenic plants and a method for controlling senescence programmed and cell death in plants |
05/29/2003 | US20030101488 Nucleotide sequences coding lyase for use in controlling aging and apoptosis in plants |
05/29/2003 | US20030101486 Schizochytrium PKS genes |
05/29/2003 | US20030101468 Unactivated oocytes as cytoplast recipients for nuclear transfer |
05/29/2003 | US20030101465 Universal stem cells |
05/29/2003 | US20030100948 Connective tissue substitutes, method of preparation and uses thereof |
05/29/2003 | US20030100726 Secreted transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100723 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100720 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
05/29/2003 | US20030100715 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
05/29/2003 | US20030100713 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100711 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100710 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
05/29/2003 | US20030100709 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cell proliferative and tumor disorders |
05/29/2003 | US20030100708 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100707 Chimeric protein for use in the treatment of viral and nervous system disorders |
05/29/2003 | US20030100531 8-30 nucleotides with 2' modified sugar moiety targeted to a nucleic acid molecule encoding human Interleukin-15, hybridizes and inhibits expression; anticancer agents and treating autoimmune diseases |
05/29/2003 | US20030100530 Thyroid stimulating hormone sensitive cell that overexpresses pituitary tumor transforming gene in response to thyroid stimulating hormone |
05/29/2003 | US20030100528 Isolated polynucleotides having a reduced or an increased content of epigenetic control motifs and uses thereof |
05/29/2003 | US20030100527 Immunostimulatory nucleic acid molecules for activating dendritic cells |
05/29/2003 | US20030100526 Operably linked mammalian muscle creatine kinase promoter, mammalian desmin promoter and enhancers thereof, and vertebrate troponin I IRE enhancer; gene therapy |
05/29/2003 | US20030100525 Amino acid sequences; anticaner agents, monitoring, diagnosis |
05/29/2003 | US20030100504 Treatment and diagnosis of insulin-resistant states |
05/29/2003 | US20030100503 Neurogenic compositions and methods |
05/29/2003 | US20030100497 For stimulating or inhibiting angiogenesis and/or cardiovascularization in mammals |
05/29/2003 | US20030100488 Osteoprotegerin binding proteins |
05/29/2003 | US20030100125 Filtering particles from liquid sample; obtain fluid sample, deposit on filter, determine time it took for fluid to pass through filter, compare to control |
05/29/2003 | US20030100109 In vitro propagation of plant seeds; prepare nutrient broth ocontaing plant growth regulators, inoculate with explant, propagate and recover cultured cells |
05/29/2003 | US20030100108 Matrix for the production of tissue engineered ligaments, tendons and other tissue |
05/29/2003 | US20030100107 Compositions and methods for generating differentiated human cells |
05/29/2003 | US20030100095 New human cathepsin |
05/29/2003 | US20030100091 Metalloprotease-disintegrin ADAM23 (SVPH3-17) |
05/29/2003 | US20030100088 Protease inhibitor conjugates and antibodies useful in immunoassay |
05/29/2003 | US20030100087 Nucleotide sequences coding protein for use in the diagnosis, prevention and treatment of tumors and cell profiferative disorders |
05/29/2003 | US20030100082 Isolation of proanthocyanidins from a flavonoid- producing cell; obtain flavonoid producing cell, culture, ferment proanthocyanidins, extract and fractionate proanthocyanidins |
05/29/2003 | US20030100076 Nucleotide sequences coding protein for use in the prevention and treatment of pancreatitis |
05/29/2003 | US20030100073 IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses |
05/29/2003 | US20030100070 Kunitz domain polypeptide Zkun11 |
05/29/2003 | US20030100065 Enzymatic polypeptide for use as tool in the fermentation of alcohols |
05/29/2003 | US20030100063 Compositions and methods for the treatment of immune related diseases |
05/29/2003 | US20030100062 Nucleotide sequences coding polypeptide for use in the treatment of arthritis, osteoporosis, liver, diabetic and inflammatory bowel diseases |
05/29/2003 | US20030100061 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030100060 Cloning, expression, sequencing, and functional enhancement of monoclonal ScFv antibody against venzuelan equine encephalitis virus (VEE) |
05/29/2003 | US20030100059 Novel cell-based assays for G-protein-coupled receptor-mediated activities |
05/29/2003 | US20030100053 Nucleotide sequences coding polypeptide for use in the treatment of tumor disorders |
05/29/2003 | US20030100052 Method for cloning and expression of BsmBI restriction endonuclease and BsmBI methylase in E. coli and purification of BsmBI endonuclease |
05/29/2003 | US20030100045 Nucleotide sequences coding polypeptide for use in carotenoid biosynthesis |
05/29/2003 | US20030100039 Novel human phospholipase c delta 5 |
05/29/2003 | US20030100026 Stimulus-inducible protein kinase complex and methods of use therefor |
05/29/2003 | US20030100021 Genetically engineered receptor for use in the detection and analysis of protein binding activity |
05/29/2003 | US20030099992 Genes associated with mast cell activation |
05/29/2003 | US20030099991 Detection of nucleotide sequences associated pain and nervous system disorders; obtain sample, incubate with probe, detect signal, recover nucleic acid, incubate with primer, amplify, evaluate for disorder |
05/29/2003 | US20030099971 Epidermal differentiation factor |
05/29/2003 | US20030099970 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof |
05/29/2003 | US20030099963 Nucleotied sequences coding polypeptide for use in the diagnosis and treatment of cancer |
05/29/2003 | US20030099926 Response element compositions and assays employing same |
05/29/2003 | US20030099671 Attenuated rabies virus with nucleoprotein mutation at the phosphorylation site for vaccination against rabies and gene therapy in the CNS |
05/29/2003 | US20030099669 Method of protein production using mitochondrial translation system |
05/29/2003 | US20030099661 Compositions and methods for the treatment of immune related diseases |
05/29/2003 | US20030099660 For regenerating tissues; antiaging agents; medical diagnosis; monitoring chemotherapy |
05/29/2003 | US20030099652 Novel human protein tyrosine kinase |
05/29/2003 | US20030099643 Methods for selectively stimulating proliferation of t cells |
05/29/2003 | US20030099631 A metalloprotease having a proteolytic activity; treating various diseases such as diabetic nephropathy, glomerulonephritis, fibrosis, cirrhosis, osteopetrosis and herniated disk; drug screening kits |
05/29/2003 | US20030099627 Method for determining modulation of p110delta activity |
05/29/2003 | US20030099625 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
05/29/2003 | US20030099623 Isolation and enrichment of neural stem cells from uncultured tissue based on cell-surface marker expression |
05/29/2003 | US20030099622 Administering a cell transplant from a donor to a recipient along with a mildly myeloablative conditioning treatment and an immune blockade treatment; prevents risk of profound neutropenia or graft-versus-host-disease (GVHD) |